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 
Abstract— Essential Tremor is the most common neurological 
movement disorder. This progressive disease causes 
uncontrollable rhythmic motions—most often affecting the 
patient's dominant upper extremity—that occur during volitional 
movement and make it difficult for the patient to perform 
everyday tasks. Medication may also become ineffective as the 
disorder progresses. For many patients, deep brain stimulation 
(DBS) of the thalamus is an effective means of treating this 
condition when medication fails. In current use, however, 
clinicians set the patient’s stimulator to apply stimulation at all 
times—whether it is needed or not. This practice leads to excess 
power use, and more rapid depletion of batteries that require 
surgical replacement. In the work described here, for the first 
time, neural sensing of movement (using chronically-implanted 
cortical electrodes) is used to enable or disable stimulation for 
tremor. Therapeutic stimulation is delivered only when the 
patient is actively using their effected limb, thereby reducing the 
total stimulation applied, and potentially extending the lifetime of 
surgically-implanted batteries. This work, which involves both 
implanted and external subsystems, paves the way for the future 
fully-implanted closed-loop deep brain stimulators. 
 




SSENTIAL Tremor (ET) is the most common 
neurological movement disorder [1] and it can have a 
dramatic impact on patient quality of life [2]. ET causes 
uncontrollable rhythmic motions—most often affecting the 
patient’s dominant upper extremity—during volitional 
movement. These uncontrollable movements make it difficult 
to perform everyday tasks such as eating, drinking, writing, or 
other activities that require fine motor control. While 
pharmaceutical agents (e.g., propranolol) can help relieve 
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symptoms for some individuals, medication is often 
ineffective or poorly tolerated in the long run: ET is a 
progressive disease, and its symptoms worsen over time [3]. 
Deep brain stimulation (DBS) of the thalamus is often used to 
give otherwise unresponsive patients control of their limb and 
freedom from disabling tremor symptoms [4,5].  
Current DBS treatment of ET is performed using a battery-
powered, implantable pulse generator (IPG) surgically 
implanted in the chest. This IPG then sends electrical 
stimulation to a lead inserted through a hole drilled in the skull 
to electrical contacts in the ventral intermediate (VIM) nucleus 
of the thalamus [5]. While the underlying causes of ET in the 
brain are unknown, and the means by which thalamic 
stimulation treats ET are unknown [6], electrical stimulation 
of the VIM can be remarkably effective for reducing tremor in 
ET patients [4,5].   
However, DBS for ET comes with several drawbacks. 
Stimulation can cause unpleasant side-effects for patients, 
such as paresthesias (abnormal facial or extremity sensations 
like tingling), dysarthria (speech impairment), and ataxia 
(dyscoordination) [7]. Additionally, most IPGs are non-
rechargeable and require surgical replacement when the 
battery is depleted. Current clinically- and FDA-approved 
DBS systems run in an “open-loop” manner, meaning that 
they deliver stimulation at a steady rate for as long as the 
device is running. Changes to this therapy require manual 
intervention by a clinician to adjust the amplitude, pulse 
width, and frequency of the stimulation waveform. This 
“open-loop” means of applying stimulation can lead to 
additional problems for the patient. Patient symptoms and side 
effects vary widely and are difficult to evoke consistently 
during bedside testing, and so it can be difficult to determine 
appropriate stimulation parameters for each patient [8]. The 
current practice of applying open loop stimulation, even at 
times when the stimulation is not necessary, is wasteful and 
can result in more frequent battery replacement surgeries or 
larger implanted devices than would otherwise be needed.  
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“Closed-loop” methods of applying stimulation, where 
IPGs use sensors to collect sensor data from the patient and 
automatically make stimulation adjustments as needed, are 
being investigated as a solution to these drawbacks. For 
example, in the case of many ET patients, a system that only 
provides stimulation when the patient is moving the affected 
limb may be capable of treating tremor while preserving 
battery life and reducing side-effects. Prior applications of 
closed-loop DBS for ET in human subjects have exclusively 
used wearable inertial sensors [9], or electromyography 
(EMG) to provide feedback for closed-loop DBS experiments 
[9,10].  
While wearable sensors are appropriate for use in an 
experimental setting, there are significant barriers to 
translating wearables to a clinically deployable system. 
Externally sensed data and externally computed control 
actions must be transmitted to the IPG. The computations 
necessary are time-intensive and introduce latency into the 
system. Further, the telemetry required to maintain a wireless 
communication channel between the IPG and external sensors 
is power intensive, and it is possible that the power lost on 
wireless telemetry would negate much of the power savings 
that closed-loop stimulation would deliver. Additionally, 
patient acceptance may be a concern, as wearing a sensor for 
much of the day may be uncomfortable, cumbersome, or draw 
unwanted attention. One possible way to address these 
potential problems with wearable closed-loop systems is to 
use signals collected from an additional set of implanted 
electrodes [11]. This would allow an implanted IPG to collect 
the data required to make control decisions without the need 
for worn sensors, off-board computations, or telemetry.  
In this paper, we demonstrate the first use of chronic 
electrocorticography (ECoG) to modulate an ET patient’s 
DBS in real-time through the use of movement-related cortical 
signals. This closed-loop system uses an investigational IPG 
with neural sensing capabilities to modulate stimulation 
amplitude based on motor cortex ECoG. We show that cortical 
movement-related beta-band desynchronization (during overt 
limb movement of the tremor-affected arm) can be used 
effectively to trigger DBS in order to reduce tremor. We 
demonstrate the efficacy of this system while the patient 
performs standard drawing tasks that are a component of a 
widely-accepted clinical tremor assessment as well as a 
prompted movement task where the patient performs 
movements that predictably cause tremor. Our system 
successfully and accurately enables and disables stimulation 
during periods of movement and rest in these trials—and, as a 
result, the system reduces the power consumed by the IPG. 
That is, the system applies therapeutic stimulation to treat 
tremor only when the patient is actively using the limb, 
thereby reducing the total amount of stimulation applied, and 
consequently may extend the lifetime of surgically-implanted 
batteries. This work paves the way for the future fully-
implanted closed-loop deep brain stimulators for use as 
therapeutic tools. It also facilitates investigation of closed-loop 
patient-device system dynamics.  
II. METHODS 
The experimental protocol used was approved by the 
Institutional Review Board at University of Washington 
Medical Center, and use of the Activa PC+S and Nexus D 
system was approved by the FDA through an Investigational 
 
Fig 1: Block diagram illustrating the experimental setup for our closed-loop DBS experiments. ECoG data, sensed by the Activa PC+S and streamed by the 
Nexus-D, is processed and classified on a laptop computer. When the Beta band-power crosses thresholds defined for movement and rest, the stimulation is 
turned on or off. Limb inertial and EMG recordings are logged and timestamped separate from the closed-loop.  
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Device Exemption. The experiments were performed in 
accordance with all relevant guidelines and regulations. The 
subject provided informed consent according to direction from 
the Institutional Review Board prior to enrollment in our 
study. 
A. Patient and surgical procedure 
The patient is a 58-year-old right-handed man who 
experiences tremor during volitional movement of his right 
arm and leg. The patient consented to participate in our study 
to implant an investigational IPG developed by Medtronic, the 
Activa PC+S. This IPG has the capability to sense through 
implanted electrodes as well as provide traditional clinical 
therapeutic stimulation. The sensed data can be streamed to an 
external computational device, such as a laptop computer, 
through the use of the Nexus-D, another investigational device 
developed by Medtronic [12].  
In addition to the unilateral DBS lead implanted in the VIM 
for therapy, we implanted a single cortical strip of electrodes 
(the Resume II lead) on the surface of the brain overlying 
motor cortex corresponding to the patient’s right hand and 
connected directly to the Activa PC+S. Motor cortex was 
localized using anatomical landmarks on preoperative MRI by 
creating an additional plan on the intraoperative navigation 
system targeting the “hand knob” in motor cortex. During 
surgery, the strip was advanced toward this target, with 
placement confirmed using intraoperative CT and adjusted to 
place two electrodes over the hand motor cortex and two 
electrodes over the sensory cortex. This strip of four 
electrodes allows for the chronic recording of neural signals 
from the cortex that have been shown to correlate with hand 
movement. Prior work with this patient demonstrated that limb 
movement may be detected using the Activa PC+S based on 
the onset of a decrease in beta power over sensorimotor cortex 
by sensing differentially across M1 to S1 [9]. The specific 
electrodes chosen was the pair with the highest beta-band 
power while the patient was at rest, determined through a 
standardized montage-sweep provided by the Activa PC+S 
instruments. We also previously demonstrated the use of 
surface electromyography (EMG) from this patient’s arm 
muscles to trigger stimulation during movement. Using EMG 
to trigger stimulation only during muscle activation resulted in 
both power savings and suppression of tremor [9]. The 
innovation of the work reported here is the use of cortical 
signals to directly drive the closed-loop control system. 
B. System Description  
The overall experimental system is represented in the block 
diagram shown in Figure 1, which outlines each component of 
this first neural closed-loop DBS system for ET. The Activa 
PC+S digitizes neural signals at a rate of 422 samples per 
second. The Activa PC+S then streams the data to a laptop 
using the Nexus-D. Each packet contains 400ms (168 
samples) of data. The laptop converts the time-domain data 
into the frequency domain, performing a 256-sample long 
FFT, with a Hann window and zero padding. We then 
summed the FFT’s discrete frequency output bins that overlap 
with the beta-band in order to estimate the patient’s beta band-
power. For this experiment, we used the bins that correspond 
to the frequency range of 14.8Hz to 31.3Hz. When the patient 
moves, the beta-band component in the signal decreases, a 
well-described phenomenon known as cortical 
desynchronization [13]. When this beta band-power drops 
below a manually-tuned threshold, the system ramps 
 
Fig 2: Cortical power-spectral density (PSD) while the patient is at rest in both 
stim on and stim off states. Note “stim on” results not only a large stimulation 
artifact at 140Hz, but also a “flattening” of the PSD with lower beta-band and 
higher gamma band activity. These PSD plots were calculated offline after the 
experiment using 20 seconds of continuous patient resting data in each state. 
 
Fig 3: Patient drawn spirals collected as part of clinical tremor assessment. On the left are two spirals drawn with the dominant hand before and after DBS 
implant. On the right are spirals collected on the day of the experiment in each of the three stimulation states. Differences in tremor between no stimulation at 
four months post-op and experimental day are attributed to day to day tremor variation. Note tremor in the upper right and lower left quadrants of the spiral in the 
experimental no stimulation case. Comparatively there are few deviations from normal spirals in the open-loop and closed-loop cases. 
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stimulation up to the normal clinical setting, or “on” state, to 
deliver therapeutic stimulation and treat the tremor. Similarly, 
when the movement ends and the motor circuits re-
synchronize, the beta band-power will rise. When it crosses a 
second manually-tuned threshold, the stimulation is turned off, 
thus conserving power when movement is not occurring. 
To simplify the development of this proof of concept, we 
iteratively tuned the thresholds used to trigger stimulation 
changes. The two manually-tuned thresholds represented the 
movement-initiation band-power threshold and the rest 
initiation band-power threshold. The range over which the 
thresholds were defined was based on the mean beta-band 
measured first while the patient was at rest with stimulation on 
and second while the patient was moving with stimulation off. 
The specific values for the movement-initiation and rest-
initiation thresholds were then manually tuned within this 
calibrated range while the patient alternated between 
movement and rest. For these experiments, the off threshold 
was calibrated to be at a higher beta band-power than the on 
threshold, which results in a dead-band between the two 
thresholds where no action is taken. We averaged the beta 
band-power estimation across five packets (or two seconds) in 
order to gain better specificity for movement detection. This 
averaging acts as a type of low-pass filter on the power signal 
and the system uses more information to make a control 
decision which reduces the impact of noise on the algorithm. 
However, averaging the feedback signal in this way introduces 
system delays that reduce overall system responsiveness.  
There are several complicating factors that need to be 
considered when designing experimental code to perform this 
task. We noticed that there was a dramatic effect of 
stimulation on the patient’s sensed cortical signal, as shown in 
Figure 2 while the patient was at rest. Turning stimulation on 
resulted in a “flattening” of the power-spectral density of the 
streamed data. While it is unclear if this flattening was due to 
physiology or device, the artifact was robust and repeatable. 
Fortunately, the magnitude of movement-related 
desynchronization was sufficient for use as a biomarker 
despite the noise in these signals and the reduction in band-
power when stimulation is present. However, the fact that 
VIM stimulation resulted in lower cortical beta was a key 
rationale for the use of two separate manually-tuned 
thresholds instead of a single one. 
C. Experimental Tasks 
To assess the experimental system, the patient performed 
two sets of tasks with no stimulation applied, open-loop 
stimulation, and closed-loop neural-triggered stimulation. To 
then quantify the tremor that the patient then experiences in 
each task or trial with the test algorithms, we performed an 
offline spectral analysis on the gyroscope data from the worn 
 
Fig 4: Task 1 results of the Fahn-Tolosa-Marin (FTM) tremor assessment task with time plots of the patient’s gyroscope magnitude, tremor estimate, cortical 
spectrogram, beta-band power estimate, and stimulation delivered with closed-loop stimulation. Red bars indicate when patient was performing one of the three 
tasks. There is a break between tasks two (connecting dots) and three (writing) where researchers changed pages. Note stimulation at zero volts before tasks 
began, during the break, and at the end of the trial 
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smartwatch. First, we summed the band-power within a low-
frequency band (approx. 4-12Hz) that captures the spectral 
power of the rhythmic tremor movement. Then as a simple 
form of artifact rejection, we scale this band-power value by 
the percentage of the total band-power measured from the 
device that is within this tremor band. This reduces the impact 
of large cross-band inertial signals that in our trials were not 
indicative of tremor but instead of task design or movement 
initiation. This method and the rational are discussed in our 
prior work with this patient during closed-loop trials using 
wearable sensors [9]. 
The first set of experimental tasks are from the commonly-
used Fahn-Tolosa-Marin tremor assessment [14], including the 
spiral draw, connecting dots, and sentence writing tasks. The 
patient was given short breaks in between the dot connecting 
and sentence writing tasks to give the researchers time to give 
the patient the next sheet of paper to work on.  
For the second task to assess the experimental system, the 
patient was then asked to complete a series of computer-
prompted tasks where he was instructed to alternate between 
resting his hand and bringing his hand to his mouth. This 
motion caused predictable tremor symptoms in this particular 
patient and facilitated a direct comparison of how each 
stimulation paradigm performed in a repeatable task. There 
were ten prompts each for movement and rest, with each 
prompt lasting for ten seconds. Each trial thus lasted a total of 
200 seconds. The prompt was delivered through both visual 
cues presented on-screen to the patient and audio cues. While 
the patient was performing these tasks, we recorded data 
related to his arm movements with a wrist-worn accelerometer 
and surface EMG. 
D. Safety Considerations 
Prior to closed-loop experiments, the patient’s therapy 
settings were configured for maximal therapeutic benefit using 
the Medtronic clinician DBS programmer (8840) in a normal 
patient-programming routine. Then, using the configured 
electrodes and determined therapeutic amplitude as a limit, we 
characterized the side effect profile while increasing the 
stimulation amplitude ramping rate between “on” (2.4 volts) 
and “off” (0 volts) states. We asked the patient to report any 
unpleasant side-effects as stimulation was ramped up and 
down repeatedly with increasingly fast slew rates so we could 
determine how fast the closed-loop algorithm could safely 
ramp stimulation between the on and off states. The interval 
between stimulation setting updates was limited to the sensing 
packet rate (400ms) to avoid losing streamed data during the 
experiments with sensing enabled. When increasing the 
stimulation by 200mV every 400ms, the patient reported mild 
paresthesias that were not unpleasant. At 1000mV every 
400ms, these sensations were more marked and surprising. 
Given his unpleasant reaction at the 1000mV level, we used 
800mV/400ms as the ramping rate for closed-loop stimulation 
testing. This would result in the system being able to transition 
between the on and off states in a total 1.2 seconds. 
 
Fig 5: Task 2 results of the movement prompting task showing average gyroscope magnitude, tremor estimate, beta-band power, and stimulation delivered for 
each of the three stimulation configurations. For all plots, red dashed lines indicate the 0.9 to 0.1 quantile bounds. The first 10 seconds of each plot is during the 
prompted movement, and timespan from 10-20 seconds corresponds to the following rest period.  On the left are the results from the no-stimulation case, as 
shown by the stimulation delivered at zero volts. In the middle are the results from the open-loop stimulation case, as shown by the 2.4V stimulation setting. On 
the right are the closed-loop results with dynamic stimulation driven by the cortical sensing. 
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III. RESULTS 
The spirals from the tremor assessment drawn during no-
stimulation, open-loop stimulation, and closed-loop 
stimulation are shown in Figure 3. Additional spirals collected 
before and four months after surgery are shown for 
comparison. As can be seen through visual inspection, the 
patient’s tremor on the day of the experiment was lower than 
previous assessments. It is well known that the severity of 
tremor can vary day to day, but even during this low-
amplitude session there are clear hallmarks of tremor in the 
spiral which were apparent in comparison to the open-loop 
case. The closed-loop case appears to be nearly identical to the 
open-loop results, indicating that the closed-loop system was 
able to significantly reduce his tremor while writing.  
All three tremor assessment writing tasks were performed 
for each stimulation paradigm, and the time-series plot of the 
closed-loop tremor assessment trial is shown in Figure 4. In 
the trial, the stimulation was turned off when the patient was 
at rest before the trials began, and during the short break in 
between the second and third tasks while the researchers 
switched pages. Stimulation was also correctly turned on for 
the duration of drawing spirals, connecting dots, and writing 
sentences.  
The results from the movement-prompting task are shown 
in Figure 5. Each of the ten pairs of movement and rest 
periods were averaged together for each of the trials with the 
three different stimulation settings. The cumulative magnitude 
of the three axes of the inertial gyroscope is displayed in the 
top row of the figure. By analyzing the gyroscopic data, we 
can estimate how much tremor the patient experienced at a 
given moment. Due to patient reaction times and time to 
transition between states, initiation of movement is offset from 
the prompts at 0 and 10 seconds by approximately 1 second; 
this is indicated by the large discrete peaks that exceed the 
window bounds. Tremor appears as a noisy signal in-between 
the transient peaks, while the patient is holding his hand at his 
mouth. The strength of the tremor is estimated through 
spectral analysis to remove the influence of the transient 
peaks, as shown in the second row.  
With no stimulation, there is tremor consistently throughout 
the prompted action and no tremor at rest. Open-loop 
stimulation results in low tremor throughout the prompted 
action and while at rest. The closed-loop system results in 
brief tremor at the start of the movement, followed by rapid 
reduction to the open-loop levels. In the third row, the average 
cortical beta-band power is shown. With stimulation off, there 
is a clear difference between the mean beta-band during rest 
and movement.  Stimulation effects on the beta band make this 
distinction more difficult to see during open-loop stimulation.  
During closed-loop stimulation, the beta-band tends to 
follow a more “normal” trend with low beta-band power 
during movement and higher beta-band power during rest. The 
average stimulation delivered in each trial is depicted in the 
final row. For the closed-loop stimulation trial, the average 
stimulation rose to clinical amplitudes during every movement 
and dropped to zero during every rest. The mean amplitude 
and quantile bounds reach 2.4 volts about five seconds after 
the prompt, indicating that for each and every movement 
period, stimulation reached clinical levels. The movement of 
the limb from the action to rest state also triggers stimulation, 
as can be seen in an average increase in the stimulation 
amplitude around 14 seconds. However, by the 18-second 
mark, prior to the next movement prompt, stimulation was off 
for all trials. 
IV. DISCUSSION 
The results show that the cortical movement-related beta-
band desynchronization is an effective signal to trigger DBS in 
order to reduce tremor. While the patient performed drawing 
tasks, the system modulated the stimulation levels 
appropriately: the system applied stimulation while the patient 
moved his arm and turned stimulation off while he was at rest. 
During the prompted movement task, the system responded 
during every action and rest period to enable and disable 
stimulation appropriately during the tasks. The system also 
performed well despite changes in beta-band power observed 
during periods when stimulation was turned on. 
Due to considerable system delays, this system was not able 
to prevent tremor at the beginning of the patient's movement. 
Sensing packets are sent through the Nexus-D telemetry 
system every 400ms, and they take an additional 100ms to 
complete each transaction. Our signal processing method 
averages two seconds’ worth of beta band-power readings 
before comparing that average to a pre-determined threshold. 
Once the threshold is exceeded, the system must wait another 
400ms before the communication channel is free (while the 
system downloads the next packet of data), before finally 
beginning to ramp the stimulation up to the clinical value over 
the course of 1.2 seconds. As such, system delays alone are on 
the order of around three seconds. 
There are a number of ways to reduce this delay in the 
future iterations of this system. In a commercial system, the 
signal processing and control computations can be moved onto 
the implanted device, removing the need for serialization 
through a small-bandwidth telemetry system. This would 
eliminate all communication and packet-interval delays, which 
currently contribute nearly 1 second of delay. More 
sophisticated classifiers might also provide faster and more 
robust recognition of movement and rest. These classifiers 
could potentially remove the need for beta-band power 
averaging and thresholding.  However, given the expected 
variability in the neural biomarkers of movement across 
patients, automated classifier training methods will need to be 
used in order for these closed-loop systems to translate into 
general clinical practice.  
It is important to consider what a final designed system’s 
desired false-positive rate should be. Since existing systems 
stimulate constantly—at what can be thought of as a very high 
false-positive rate—any incremental reductions in stimulation 
time while maintaining tremor suppression is a clear 
improvement. By tuning the system to be more aggressive in 
applying stimulation, we may lose some specificity and have a 
higher false-positive rate, but obtain a reduced delay and thus 
do a better job of obtaining overall therapeutic benefit. 
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Another consideration is that other ECoG signals could be 
used for closed-loop control. For instance, prior work in the 
BCI field has identified that there are movement-related 
changes in both the beta and gamma bands [13,15]. While the 
system used in this experiment was not able to make use of the 
gamma band due to limitations imposed by communication 
data compression in the Nexus-D [9], gamma signals are more 
localized on the motor cortex and are more task specific than 
beta-band changes. Including gamma-band signals may 
improve a system’s ability to determine when a patient is 
moving their limb and needs stimulation in the future. 
Additionally, research conducted with Parkinson’s Disease 
patients suggests that some abnormal cortical signals may 
correspond to movement disorder symptoms [16]. Future work 
may find biomarkers that indicate when an ET patient is 
experiencing tremors, and such a biomarker would allow us to 
limit stimulation only to periods when the patient is 
experiencing tremor. 
When discussing system performance, it is important to 
consider the patient’s experience as modulation of stimulation 
parameters could have an impact on patient quality of life 
[8,17]. To gauge the potential impact of closed-loop control on 
the patient’s everyday experience, we conducted semi-
structured interviews with the patient during each research 
visit [18]. When asked if the tremor at the beginning of 
movement is bothersome, the patient responded, “It’s not that 
big of a deal. You get used to it.” Given that by the time 
patients receive a DBS system they have often adapted to 
living with tremor for quite some time, the transient effects 
may be of less concern to many patients, as long as they reach 
their desired tremor-free state in a predictable time frame. 
However, it must be noted that in order for any algorithm to 
be viable, it must save more stimulation power than is used in 
the sensing and processing of data to deliver the closed-loop 
therapy. The exact cut-off for this balancing point would 
depend heavily on the hardware and firmware implementation, 
although with the continual drive to deliver lower-powered 
circuitry there may be a point where highly sophisticated 
algorithms may be used without concern of the sensing or 
processing power. It has been estimated that for an Activa 
PC+S system with typical stimulation parameters, a closed-
loop DBS system that was triggered (or actively stimulating) 
for 94% of the time would have equal energy usage as an 
open-loop system [19]. This means that even minor or modest 
reductions in stimulation power will be worth the additional 
system components to allow devices to utilize closed-loop 
methods.  
V. CONCLUSION 
In conclusion, this paper documents the first successful 
demonstration in an ET Patient of a fully-implanted sensing 
and stimulation platform for neural-triggered, closed-loop 
DBS. To the best of the authors’ knowledge, this is the first 
use of voluntary motor neural signals to drive therapeutic 
stimulation in real-time. Moreover, this technology, by 
providing access to simultaneous chronic recordings from 
deep brain and cortical structures, may enable increased 
understanding of the mechanisms of tremor and tremor 
suppression. While the current system uses an external 
computer for data logging, processing, and control, 
forthcoming versions of the IPG (from Medtronic) will likely 
be able perform these operations on hardware embedded 
within the implanted device, so that no external 
communication would be required. We have demonstrated 
here a system that is able to modulate delivery of DBS by 
identifying volitional movement, providing tremor reduction 
in an ET patient. Further work using this paradigm may realize 
a feasible, fully-implanted system for the delivery of demand-
driven therapy for ET. 
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